[1]CurrentPatentAssignee:ASTRAZENECAPLC-US2006/135770,2006,A1Locationinpatent:Page/Pagecolumn23-24
[1]BioorganicandMedicinalChemistryLetters,2009,vol.19,p.4416-4420
1003710-01-7
1003709-96-3
1583-65-9
1583-58-0
2967-93-3
28314-80-9
135637-46-6 | 2(1H)-Pyrimidinone,5-[3-[(1S,2S,4R)-bicyclo[2.2.1]hept-2-yloxy]-4-methoxyphenyl]tetrahydro- | AA006YEI | MFCD00937750
223381-71-3 | 4-(Azetidin-3-yl)morpholine hydrochloride | AA006YSM | MFCD11865371
431-87-8 | 2-chloro-1,1,1,3,3,3-hexafluoro-propane | AA006Z8E | MFCD01698452
477284-75-6 | TETRAKIS(ETHYLMETHYLAMINO)SILANE | AA006ZNM | MFCD05663777
13692-14-3 | Alpha-(chloromethyl)-2,4-dichlorobenzyl alcohol | AA00706V | MFCD00000950
134419-59-3 | Oxan-4-yl methanesulfonate | AA0070M4 | MFCD11505063
13618-93-4 | Octahydroindolizine | AA00711S | MFCD02066234
4460-15-5 | N2-(4-Methoxyphenyl)-1,3,5-triazine-2,4-diamine | AA0071HB | MFCD00973837
46713-38-6 | 1,1'-Diethyl-4,4'-bipyridinium | AA0071YI | MFCD32661408
4241-27-4 | 2-Hydroxy-6-methylnicotinonitrile | AA0072F5 | MFCD00006013